Multiple Sclerosis in Pregnancy: A Commentary on Disease Modification and Symptomatic Drug Therapies Priyanka IyerRuth Dobson Commentary Open access 28 November 2022 Pages: 1 - 10
The Early Diagnosis of Alzheimer’s Disease: A Patient-Centred Conversation with the Care Team Ziad NasreddineValentina GaribottoAlessandro Padovani COMMENTARY Open access 18 December 2022 Pages: 11 - 23
Treatment with Cladribine Tablets Beyond Year 4: A Position Statement by Southeast European Multiple Sclerosis Centers Mario HabekJelena DrulovicPeter Turčáni Guidelines Open access 17 November 2022 Pages: 25 - 37
Non-drug Therapies for Alzheimer’s Disease: A Review Xianqian LiMin JiJianqun Gao Review Open access 14 November 2022 Pages: 39 - 72
Galcanezumab Effects on Migraine Severity and Symptoms in Japanese Patients with Episodic Migraine: Secondary Analysis of a Phase 2 Randomized Trial Hisaka IgarashiMamoru ShibataTaka Matsumura Original Research Open access 20 October 2022 Pages: 73 - 87
Validation of a Set of Instruments to Assess Patient- and Caregiver-Oriented Measurements in Spinal Muscular Atrophy: Results of the SMA-TOOL Study Juan F. Vázquez-CostaMaría Branas-PampillónMarcos Madruga-Garrido Original Research Open access 21 October 2022 Pages: 89 - 105
Understanding the Symptom Burden and Impact of Myasthenia Gravis from the Patient’s Perspective: A Qualitative Study Kristi JacksonAnju ParthanCarolina Barnett Original Research Open access 02 November 2022 Pages: 107 - 128
Brain Complexity Predicts Response to Adrenocorticotropic Hormone in Infantile Epileptic Spasms Syndrome: A Retrospective Study Chu-Ting ZhangYu-Lin SunChien-Hung Yeh Original Research Open access 03 November 2022 Pages: 129 - 144
Real-World Analysis Affirms the High Persistence and Adherence Observed with Diroximel Fumarate in Patients with Multiple Sclerosis Brittney LagerJacob LisenoJames B. Lewin Original Research Open access 05 November 2022 Pages: 145 - 159
Association between Serum Amyloid A Level and White Matter Hyperintensity Burden: a Cross-Sectional Analysis in Patients with Acute Ischemic Stroke Peng ZhangRongrong HanDaojing Li Original Research Open access 14 November 2022 Pages: 161 - 175
Disease Progression and Longitudinal Clinical Outcomes of Lewy Body Dementia in the NACC Database Julie ChandlerMihaela GeorgievaKevin Biglan Original Research Open access 15 November 2022 Pages: 177 - 195
Effect of ANKK1 Polymorphisms on Serum Valproic Acid Concentration in Chinese Han Adult Patients in the Early Postoperative Period Jiuhong MaXiuzhao FanJinlin Guo Original Research Open access 18 November 2022 Pages: 197 - 209
Treatment Preference for Alzheimer’s Disease: A Multicriteria Decision Analysis with Caregivers, Neurologists, and Payors George DranitsarisQuanwu ZhangAmir Abbas Tahami Monfared Original Research Open access 23 November 2022 Pages: 211 - 227
The Lived Experiences of People with Progressive Supranuclear Palsy and Their Caregivers Gesine RespondekDiane BreslowCecile Vanderavero Original Research Open access 29 November 2022 Pages: 229 - 247
Psychomotor Vigilance Performance in Participants with Excessive Daytime Sleepiness in Obstructive Sleep Apnea or Narcolepsy Compared with SAFTE-FAST Model Predictions Jaime K. DevineLindsay SchwartzGert Jan Lammers Original Research Open access 10 December 2022 Pages: 249 - 265
Characteristics of Patients with Hereditary Transthyretin Amyloidosis-Polyneuropathy (ATTRv-PN) in NEURO-TTRansform, an Open-label Phase 3 Study of Eplontersen Teresa CoelhoMárcia Waddington CruzJohn L. Berk Original Research Open access 16 December 2022 Pages: 267 - 287
Sphingosine-1 Phosphate Receptor Modulators Increase In Vitro Melanoma Cell Line Proliferation at Therapeutic Doses Used in Patients with Multiple Sclerosis Caroline Ruetsch-ChelliDarin T. OkudaChristine Lebrun-Frenay ORIGINAL RESEARCH Open access 16 December 2022 Pages: 289 - 302
Serum Neurofilament Light Trajectories and Their Relation to Subclinical Radiological Disease Activity in Relapsing Multiple Sclerosis Patients in the APLIOS Trial Amit Bar-OrXavier MontalbanEdward Fox ORIGINAL RESEARCH Open access 19 December 2022 Pages: 303 - 317
Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder: Onset Following Acute COVID-19 Infection, a Case Series Mirla AvilaYuanyuan TanVictor M. Rivera Case Series Open access 18 November 2022 Pages: 319 - 327
Letter to the Editor Regarding Fleischer et al. Neurological Study Does Not Provide Any Evidence that Long COVID is Psychosomatic Mark VinkTilman GrandeMatthias Kohl Letter Open access 12 December 2022 Pages: 329 - 332
Response Letter to Vink et al. ‘Neurological Study Does Not Provide Any Evidence that Long COVID is Psychosomatic’ Mark StettnerMichael FleischerChristoph Kleinschnitz Letter Open access 12 December 2022 Pages: 333 - 336
